ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $673.21 million. The enterprise value is $405.72 million.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 295.27 million shares outstanding. The number of shares has increased by 60.61% in one year.
| Current Share Class | 135.98M |
| Shares Outstanding | 295.27M |
| Shares Change (YoY) | +60.61% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | 18.54% |
| Owned by Institutions (%) | 15.09% |
| Float | 87.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 904.85 |
| Forward PS | n/a |
| PB Ratio | 2.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 545.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.32 |
| Quick Ratio | 9.39 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33,176.60 |
Financial Efficiency
Return on equity (ROE) is -41.81% and return on invested capital (ROIC) is -26.84%.
| Return on Equity (ROE) | -41.81% |
| Return on Assets (ROA) | -25.09% |
| Return on Invested Capital (ROIC) | -26.84% |
| Return on Capital Employed (ROCE) | -51.43% |
| Revenue Per Employee | $3,647 |
| Profits Per Employee | -$348,201 |
| Employee Count | 204 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ProKidney has paid $3.70 million in taxes.
| Income Tax | 3.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.22% in the last 52 weeks. The beta is 1.80, so ProKidney's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | +11.22% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 32.71 |
| Average Volume (20 Days) | 1,643,270 |
Short Selling Information
The latest short interest is 12.29 million, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 12.29M |
| Short Previous Month | 10.74M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 14.02% |
| Short Ratio (days to cover) | 5.80 |
Income Statement
In the last 12 months, ProKidney had revenue of $744,000 and -$71.03 million in losses. Loss per share was -$0.55.
| Revenue | 744,000 |
| Gross Profit | 744,000 |
| Operating Income | -165.88M |
| Pretax Income | -155.54M |
| Net Income | -71.03M |
| EBITDA | -159.57M |
| EBIT | -165.88M |
| Loss Per Share | -$0.55 |
Full Income StatementBalance Sheet
The company has $271.73 million in cash and $4.24 million in debt, giving a net cash position of $267.49 million or $0.91 per share.
| Cash & Cash Equivalents | 271.73M |
| Total Debt | 4.24M |
| Net Cash | 267.49M |
| Net Cash Per Share | $0.91 |
| Equity (Book Value) | 318.34M |
| Book Value Per Share | -7.41 |
| Working Capital | 270.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$111.78 million and capital expenditures -$34.95 million, giving a free cash flow of -$146.73 million.
| Operating Cash Flow | -111.78M |
| Capital Expenditures | -34.95M |
| Free Cash Flow | -146.73M |
| FCF Per Share | -$0.50 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -22,296.10% |
| Pretax Margin | -20,906.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ProKidney does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.61% |
| Shareholder Yield | -60.61% |
| Earnings Yield | -10.55% |
| FCF Yield | -21.80% |
Dividend DetailsAnalyst Forecast
The average price target for ProKidney is $6.25, which is 174.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.25 |
| Price Target Difference | 174.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 440.09% |
| EPS Growth Forecast (5Y) | -16.41% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
